Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | PDE5A | O76074 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | GSK3A | P49840 | 3/20 | 0.46 |
| ▸ | GSK3B | P49841 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | AURKA | O14965 | 1/20 | 0.45 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30300332 | 1.00 | MAPT (0.51) | MAPTSMN1; SMN2USP2CYP3A4PDE5A | |
| Ammonia Solution, Strong SCHEMBL3942500 | 0.91 | MAPT (0.46) | MAPTSMN1; SMN2USP2CYP3A4PDE5A | |
| SCHEMBL943860 | 0.87 | PKM (0.54) | MAPTSMN1; SMN2USP2ALDH1A1GSK3A | |
| SCHEMBL10415830 | 0.82 | CYP2A6 (0.43) | MAPTSMN1; SMN2USP2PDE5AALDH1A1 | |
| SCHEMBL16199534 | 0.82 | MAPT (0.53) | MAPTSMN1; SMN2USP2ALDH1A1GSK3A | |
| SCHEMBL31739246 | 0.80 | GSK3A (0.51) | MAPTSMN1; SMN2CYP3A4PDE5AGSK3A | |
| SCHEMBL5098907 | 0.79 | BCL2L1 (0.52) | MAPTSMN1; SMN2USP2ALDH1A1GSK3A | |
| SCHEMBL5091184 | 0.79 | MAPT (0.49) | MAPTSMN1; SMN2USP2ALDH1A1GSK3A | |
| SCHEMBL97197 | 0.78 | NPC1 (0.48) | MAPTSMN1; SMN2CYP3A4ALDH1A1HSD17B10 | |
| SCHEMBL9432285 | 0.78 | CYP3A4 (0.48) | MAPTSMN1; SMN2CYP3A4ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 387 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| WO-2024190663-A1 | BIOMARKER AND USE THEREOF | 株式会社明治 | 2024-09-19 | — | — | WO | claimed |
| CN-113024530-B | Isatin-1, 2, 4-oxadiazole compound and preparation method and application thereof | 合肥工业大学 | 2023-07-18 | — | — | CN | claimed |
| CN-110314692-B | Heteropolyacid and method for synthesizing piperonyl nitrile by using heteropolyacid as catalyst | 和德化学(苏州)有限公司 | 2022-04-05 | — | — | CN | claimed |
| CN-113024530-A | Isatin-1, 2, 4-oxadiazole compound and preparation method and application thereof | 合肥工业大学 | 2021-06-25 | — | — | CN | claimed |
| EP-2979682-A1 | A fragrance composition | Symrise AG (DE) | 2016-02-03 | — | — | EP | claimed |
| US-20100104644-A1 | Compositions and Methods for Treating or Preventing Ophthalmic Disease | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2010-04-29 | — | — | US | claimed |
| US-20090291919-A1 | Compositions and Methods for Treating or Preventing Ophthalmic Light Toxicity | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2009-11-26 | — | — | US | claimed |
| US-20090286808-A1 | Opsin Stabilizing Compounds and Methods of Use | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2009-11-19 | — | — | US | claimed |
| EP-2069391-A2 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OPHTHALMIC DISEASE | University of Florida Research Foundation, Inc. (US) | 2009-06-17 | — | — | EP | claimed |
| US-6573397-B2 | Chlorinating 3,4-methylenedioxybenzonitrile with sulfuryl chloride or chlorine in presence of promoter to form 2-chloro-benzo(1,3)dioxole-5-carbonitrile, hydrolyzing with water to produce 3,4-dihydroxybenzonitrile | UBE INDUSTRIES, LTD. (JP) | 2003-06-03 | — | — | US | claimed |
| WO-2003043976-A1 | METHOD FOR PRODUCING 3,4-DIHYDROXYBENZONITRILE | LONZA AG (CH) | 2003-05-30 | — | — | WO | claimed |
| US-20030009048-A1 | Process for producing 3,4-dihydroxybenzonitrile | UBE INDUSTRIES, LTD. | 2003-01-09 | — | — | US | claimed |
| EP-1270550-A1 | Process for producing 3, 4-Dihydroxybenzonitrile | Ube Industries, Ltd. (JP) | 2003-01-02 | — | — | EP | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090291919-A1 | Compositions and Methods for Treating or Preventing Ophthalmic Light Toxicity | ALDH1A2, EYA3, PDE6C | MAPT 1961/4885SMN1; SMN2 4664/4885USP2 1814/4885 |
| US-20100104644-A1 | Compositions and Methods for Treating or Preventing Ophthalmic Disease | ALDH1A2, PDE6C, EYA3 | MAPT 2030/4885SMN1; SMN2 3321/4885USP2 1853/4885 |
| US-20030009048-A1 | Process for producing 3,4-dihydroxybenzonitrile | BPNT1, DCUN1D4, CPN1 | MAPT 4834/4885SMN1; SMN2 4145/4885USP2 841/4885 |
| US-20090286808-A1 | Opsin Stabilizing Compounds and Methods of Use | CRYZ, NR2E3, CRYAB | MAPT 467/4885SMN1; SMN2 231/4885USP2 2423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.